What Cowin Capital does

Cowin Capital (同创伟业, legal name: Shenzhen Cowincapital Asset Management Co., Ltd.) is a private venture capital and private equity firm founded in 2000 and headquartered in Shenzhen, China. The firm is one of China's earliest domestic brand professional VC institutions and serves as the manager of Nanhai Growth-China's first limited partnership fund. Cowin Capital operates multiple RMB and USD denominated investment funds with 51-100 employees across five Chinese cities (Shenzhen, Beijing, Shanghai, Hangzhou, Suzhou), targeting early-stage to pre-IPO technology companies across four core verticals: large technology (大科技/hard tech), large healthcare (大健康/biopharma and medical devices), large information (大信息/TMT and digital economy), and large consumption (大消费).

The firm's core products are investment management services and fund management, supplemented by a quarterly refinancing roadshow platform co-hosted with the Shenzhen Stock Exchange's Kerongtong V-Next platform. Its 700+ portfolio companies include semiconductor EDA (Shanghai LiXin), embodied AI robotics (Manifold AI, Zero Square Robotics, Zhongke Fifth Era), automotive electronics (Aotec, listed April 2026), optical chips (WinCO/Huachen Xinguang), AI chips (Xingyun Integrated Circuit), rare earth materials (Jinrui Da), medical imaging (Beta Pharma ecosystem), and consumer 3D printing (Snapmaker). Recent activity shows a clear thematic shift toward AI infrastructure, world models, humanoid robotics, commercial aerospace, and new energy materials aligned with China's "new productive forces" strategic agenda.

Cowin Capital generates revenue through traditional VC mechanisms, including management fees on managed funds (RMB and USD denominated) and carried interest from successful exits. The firm has executed 200+ successful exits spanning IPOs on STAR Market, ChiNext, Beijing Stock Exchange, HKEX, and NASDAQ. The firm distributes capital through direct investment into portfolio companies sourced via its website contact portal, industry events, roadshows, and referral networks. With 25 years of operating history, Cowin Capital has built an established position in China's domestic VC industry with documented recognition including 投中榜 2024 Qingdao Investment Partner Top 20 and the 2023 Qingdao Government Guidance Fund Best Partner award.

Name

Cowin Capital

Legal name

深圳同创伟业资产管理股份有限公司

Website

https://cowincapital.com.cn

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Cowin Capital is a Shenzhen-headquartered Chinese venture capital firm founded in 2000, managing RMB and USD funds across hard tech, healthcare, TMT, and consumer sectors. With 700+ portfolio companies and 200+ successful exits spanning STAR, ChiNext, BSE, HKEX, and NASDAQ, the firm serves Chinese technology entrepreneurs from early stage through IPO.

Ownership category

akta.pro rank

Product category

Venture Capital and Private Equity

NAICS

Portfolio Management and Investment Advice (52394)

SIC

Finance Services (6199)

akta.pro primary industry

Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

Keywords

• Venture capital investment
• Private equity funds
• Growth stage equity
• Healthcare biotech investing
• Hard technology investment

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Management: Cowin Capital generates revenue through traditional VC mechanisms including management fees on managed funds and carried interest (performance fees) from successful exits. The firm has achieved 200+ successful exits including numerous IPOs on Shanghai Stock Exchange (科创板), Shenzhen ChiNext (创业板), Beijing Stock Exchange (北交所), Hong Kong Exchange (港交所), and NASDAQ.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Cowin Capital is a venture capital and private equity firm that raises capital into multiple RMB and USD-denominated funds from limited partners and invests that capital as equity into early-stage and growth-stage companies across hard technology, healthcare/biotech, TMT, and consumer sectors. The firm manages the investment lifecycle from deal sourcing and due diligence through board-level portfolio support to exit via IPO on Chinese and overseas exchanges or M&A. It also operates a quarterly re-financing roadshow platform with the Shenzhen Stock Exchange to connect portfolio companies with institutional investors.

Product overview

Cowin Capital (同创伟业) is a venture capital and investment management firm providing fund management services and financing support to emerging technology companies. The firm operates specialized investment funds across four core sectors: large technology (大科技), healthcare (大健康), TMT/information technology (大信息), and consumption (大消费). With 25 years of investment experience, the firm has invested in over 700 companies and achieved more than 200 successful exits. The core product offering consists of investment management services and fund operations, supplemented by a quarterly re-financing roadshow platform that connects portfolio companies with institutional investors through events organized with the Shenzhen Stock Exchange's科融通V-Next platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Investment Management Services Venture capital and private equity investment management services for emerging technology companies, spanning sectors including AI, semiconductors, robotics, biotech, advanced manufacturing, commercial aerospace, and new energy materials. Provided to portfolio companies and limited partner investors from Cowin's RMB and USD-denominated funds.
• Multi-Sector Fund Management (RMB and USD Denominated Funds) Management of specialized investment funds across four core sectors: large technology (hard tech), large healthcare (biotech and pharma), large information (TMT and digital economy), and large consumer, with over 700 portfolio companies and 200+ successful exits to date. Offered to limited partner investors including government guidance funds, state-owned investors, financial institutions, and high-net-worth individuals.
• Quarterly Re-financing Roadshow Platform Regular financing roadshow events co-organized with the Shenzhen Stock Exchange's "Kechuangtong V-Next" platform, featuring pre-IPO and growth-stage portfolio companies seeking capital from institutional investors. Provides portfolio companies with privileged access to institutional investor networks.

Quantifiable outcome

• 25 years investment management experience
• +4 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• 深交所科融通V-NextcoreStrategic or Co-development Partner · 11 June 2026Joint hosting of Q2 2026 re-financing project roadshow, attracting nearly 100 top-tier investment institutions, industry leaders, and experts.
• 深交所科融通V-Next平台coreStrategic or Co-development PartnerCowin Capital co-hosts quarterly re-financing roadshows with the Shenzhen Stock Exchange's '科融通V-Next' platform to connect portfolio companies with institutional investors. The June 2026 Q2 roadshow featured 9 companies in AI+ industry, commercial aerospace, and new energy materials sectors.
• 贝达药业coreStrategic or Co-development PartnerStrategic ecosystem partnership where Cowin Capital organizes portfolio companies to visit and collaborate with 贝达药业 (Beta Pharma). Joint activities include company visits, executive dialogues, and pitch sessions to foster collaboration between Cowin portfolio companies and the pharmaceutical ecosystem.
• 宇树科技 (Unitree)coreStrategic or Co-development PartnerCowin Capital portfolio company 中科第五纪 became Unitree's '核心生态合作伙伴' (core ecosystem partner), focusing on embodied intelligence brain and controller development.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Hillhouse Capital (高瓴资本): One of Asia's largest alternative asset managers, with deep exposure to Chinese technology and healthcare startups across all stages. Directly comparable to Cowin Capital in sector focus and Chinese-market orientation, but materially larger in AUM and headcount.
• Sequoia China (红杉中国): Premier Chinese venture and growth investor across technology, healthcare, and consumer. Closely comparable to Cowin in stage range and sector mix; competes head-to-head for many of the same hard-tech and AI deals.
• IDG Capital: Pioneer foreign-affiliated VC in China investing across technology, healthcare, and advanced manufacturing. Comparable stage and sector focus, with a longer operating history and broader international LP base.
• CDH Investments (鼎晖投资): Large Chinese alternative asset manager spanning PE, VC, and real assets. Comparable in scale and breadth, though heavier weighting toward buyout/PE relative to Cowin's VC tilt.

Direct peers

• Northern Light Venture Capital (北极光创投): Early- and growth-stage Chinese VC focused on hard tech, healthcare, and TMT. Closest peer in fund size, headcount band, and sector mix; competes for the same sub-$100M rounds in chips, AI, and biotech.
• MatrixPartners China (经纬中国): Early-stage Chinese VC investing in technology, healthcare, and consumer with a comparable stage focus and deal cadence. Direct competitor for AI, robotics, and biotech seed/Series A opportunities.
• Shunwei Capital (顺为资本): Chinese tech-focused VC founded by Lei Jun with a comparable stage range and portfolio tilt toward AI, smart hardware, and advanced manufacturing. Frequently co-invests or competes in Cowin's target deal flow.
• Legend Capital (君联资本): Growth-stage Chinese VC/PE under Legend Holdings with strong healthcare and TMT franchises. Highly comparable to Cowin's healthcare-weighted portfolio and similar fund sizing.
• Source Code Capital (源码资本): Chinese VC focused on technology, particularly enterprise software, AI, and deep tech. Comparable stage focus and deal flow, with stronger emphasis on software and platform business models.
• ZhenFund (真格基金): Angel- and early-stage Chinese VC with broad tech and consumer coverage. Comparable in Chinese-market orientation and breadth of portfolio, though typically writing smaller checks at earlier stages than Cowin.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments412 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cowin Capital